We help biotech and pharmaceutical companies advance their clinical programs with the hands-on support of seasoned industry operators who have led development from the inside.

Our consultants have served as executives in the industry ranging from early-stage gene therapy startups to global biopharmaceutical companies. They have built clinical organizations from the ground up, filed INDs, led FDA and EMA interactions, designed first-in-human trials, advanced programs from Phase II into pivotal development, and supported NDA preparation. These are former industry executives with an average of 20+ years’ experience who have managed clinical programs, presented to boards, and navigated the regulatory process firsthand. They understand both the science and the operational realities of getting drugs to patients.

We work with biotech and pharmaceutical companies at all stages of development, from companies preparing for their first clinical trial to those advancing late-stage assets toward registration. We also support life science investors conducting clinical and regulatory due diligence and academic institutions seeking to translate promising science into viable clinical programs.

Our consultants bring deep expertise across oncology, gene therapy, immunology, neuroscience, and cardiometabolic disease, with experience navigating FDA, EMA, and other major regulatory authorities across both the US and Europe. Whether your program needs strategic direction, hands-on execution support, or senior clinical leadership on an interim basis, we assemble the right expertise for your specific situation.